Pharma and healthcare funds have delivered an average return of 6.5 per cent over the past three months and 54.6 per cent over the past year. Investors are drawn to this sector for its robust business prospects and defensive qualities.
Pharma, which has several sub-segments, offers broad diversification. "Pharma funds provide ample diversification opportunities with investments across branded pharma (comparable to FMCG), US generics (comparable to commodities), APIs (or Active Pharmaceutical Ingredients, comparable to manufacturing), and hospitals & diagnostics (comparable to retail/premiumisation)," says Meeta Shetty, fund manager, Tata Mutual Fund.
Altogether, 26 funds focused on pharma and healthcare collectively manage ₹30,306 crore. Some of them offer exposure to global pharma stocks.
Big growth runway
هذه القصة مأخوذة من طبعة October 31, 2024 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة October 31, 2024 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
IndiGo stock takes off on rating upgrade
Elara Capital gives 'buy' rating after IndiGo's highest-ever traffic in November
Wait for NAV, price on exchange to converge before investing
Indian investors seeking to diversify their portfolios through overseas exchange-traded funds (ETFs) are paying a premium.
Multiple triggers for Vedanta stock
Vedanta’s stock is experiencing multiple positive triggers, primarily driven by favorable aluminium and zinc price trends. The company's demerger plans, while modified, are expected to unlock value and improve capital allocation. Key projects coming online in the next 12-18 months, including alumina refinery expansion and captive mines, are poised to significantly boost earnings.
Markets settle flat in muted trade
Benchmark indices Sensex and Nifty ended flat in listless trading on Thursday amid a lack of near-term triggers and unabated foreign fund outflows.
India Third-Best Performing Major Market in 2024
The domestic market capitalization has soared 18.4 percent to $5.18 trillion in 2024, adding $806 billion.
MP High Court stays Burmans' Religare open offer
In a strange turn of events, the Madhya Pradesh High Court's Jabalpur Bench has stayed the Burman family's open offer to acquire an additional 26 per cent stake in Religare Enterprises, and the company's annual general body meeting.
IPO Mopup Likely to Top ₹2 Trillion Mark Next Year
Fund mobilisation through initial public offerings (IPOs) will continue to rise in 2025 and the total amount is expected to breach the ₹2 trillion mark, investment banking firm Pantomath Group estimates.
Derivatives volume drops 37%
Stricter trading norms help cool off speculative activity in December so far
Indian crypto investors ride Bitcoin, altcoin wave
The majority of crypto investors in the country have invested in mainstream virtual digital assets (VDAs) such as Bitcoins, altcoins like Dogecoin, Shiba Inu, and Ethereum, followed by non-fungible tokens (NFTs) and stablecoins, a compilation of year-end reports of crypto majors CoinDCX and CoinSwitch revealed.
28% OF LS SEATS HAD NO WOMAN CANDIDATE IN 2024
The Election Commission of India on Thursday released 42 statistical reports for the Lok Sabha (LS) elections 2024.
